> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# New England Journal Under Attack
- URL: https://www.fdaweb.com/new-england-journal-under-attack/
- Published: 2016-04-05T12:00:00.000Z
- Updated: 2026-09-14T20:52:59.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5135282

> The *New England Journal of Medicine*, considered by many to be the best known and most venerated such journal in the world, is now the subject of concerns that it is slipping in relevancy and reputation, according to a *ProPublica* [report](https://www.propublica.org/article/amid-public-feuds-a-venerated-medical-journal-finds-itself-under-attack?ref=fdaweb.com) co-published with the *Boston Globe* The report discusses a number of well-publicized feuds with prominent medical researchers and former *Journal* editors over whether the publication and its current leadership have resisted correcting errors and lag behind others in an industry-wide push for more openness in medical research. Critics also say that dissent has been dismissed with a paternalistic arrogance.  
>  
> *NEJM* editor-in-chief **Jeffrey Drazen** told *ProPublica* that the criticisms are misguided. He said the goal is always for the research that the *Journal* publishes to be accurate, while its editorials are designed to be “controversial” as a means of inciting discussion.  
>  
> “If there’s anything that I have a passion for, it’s getting it right,” Drazen said. “We work very hard at that. We’re not arrogant. We’re not dismissive.”